NICOX SA EUR1 Company Profile (NASDAQ:NICXF)

About NICOX SA EUR1 (NASDAQ:NICXF)

NICOX SA EUR1 logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NICXF
  • CUSIP: N/A
  • Web: N/A
Average Prices:
  • 50 Day Moving Avg: $12.96
  • 200 Day Moving Avg: $10.71
  • 52 Week Range: $7.88 - $14.03
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -40.00
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $18,269.00
  • Price / Sales: N/A
  • Book Value: $4.79 per share
  • Price / Book: 2.76
Profitability:
  • EBIDTA: ($23,160,000.00)
Misc:
  • Average Volume: 4,784 shs.
 

Frequently Asked Questions for NICOX SA EUR1 (NASDAQ:NICXF)

What is NICOX SA EUR1's stock symbol?

NICOX SA EUR1 trades on the NASDAQ under the ticker symbol "NICXF."

Who are some of NICOX SA EUR1's key competitors?

How do I buy NICOX SA EUR1 stock?

Shares of NICOX SA EUR1 can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NICOX SA EUR1's stock price today?

One share of NICOX SA EUR1 stock can currently be purchased for approximately $13.20.


MarketBeat Community Rating for NICOX SA EUR1 (NASDAQ NICXF)
Community Ranking:  1.0 out of 5 ()
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  64
MarketBeat's community ratings are surveys of what our community members think about NICOX SA EUR1 and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for NICOX SA EUR1 (NASDAQ:NICXF) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for NICOX SA EUR1 (NASDAQ:NICXF)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for NICOX SA EUR1 (NASDAQ:NICXF)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for NICOX SA EUR1 (NASDAQ:NICXF)
Current Year EPS Consensus Estimate: $-0.79 EPS
Next Year EPS Consensus Estimate: $-0.33 EPS

Dividends

Dividend History for NICOX SA EUR1 (NASDAQ:NICXF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NICOX SA EUR1 (NASDAQ:NICXF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for NICOX SA EUR1 (NASDAQ:NICXF)
Latest Headlines for NICOX SA EUR1 (NASDAQ:NICXF)
Source:
DateHeadline
finance.yahoo.com logoNICOX : Number of voting rights as of July 17, 2017
finance.yahoo.com - July 19 at 12:13 AM
finance.yahoo.com logoNICOX : Number of voting rights as of June 30. 2017
finance.yahoo.com - July 4 at 12:56 AM
americanbankingnews.com logoZacks: NICOX SA EUR1 (NICXF) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - July 3 at 11:02 AM
seekingalpha.com logoNicox (NICXF) Presents At BIO International Conference 2017 - Slideshow
seekingalpha.com - June 23 at 8:27 AM
finance.yahoo.com logoNicox to present at the 2017 BIO International Convention
finance.yahoo.com - June 16 at 8:12 AM
finance.yahoo.com logoNicox: Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to existing Aciex shareholders following the US FDA's approval of ZERVIATE
finance.yahoo.com - June 8 at 7:44 PM
finance.yahoo.com logoNICOX : Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to former Aciex shareholders following the US FDA's approval of ZERVIATE
finance.yahoo.com - June 8 at 7:44 PM
americanbankingnews.com logoNICOX SA EUR1 (NICXF) Downgraded by Zacks Investment Research
www.americanbankingnews.com - June 6 at 7:12 AM
seekingalpha.com logoNicox Eyes Partner After First Approval
seekingalpha.com - June 5 at 8:54 AM
finance.yahoo.com logoNICOX : Number of voting rights as of May 31, 2017
finance.yahoo.com - June 1 at 7:41 PM
americanbankingnews.com logo NICOX SA EUR1 (NICXF) Given Average Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - June 1 at 12:48 PM
finance.yahoo.com logoNicox: Report on the termination of the liquidity agreement with Gilbert Dupont
finance.yahoo.com - June 1 at 9:00 AM
finance.yahoo.com logoMs. Lauren P. Silvernail appointed to Nicox Board of Directors
finance.yahoo.com - May 17 at 8:57 AM
finance.yahoo.com logoNICOX : Total number of voting rights as of April 30. 2017
finance.yahoo.com - May 2 at 7:16 PM
finance.yahoo.com logoNicox first quarter 2017 business update and cash position
finance.yahoo.com - April 27 at 9:58 AM
finance.yahoo.com logoNicox announces PDUFA date for ZERVIATE NDA
finance.yahoo.com - April 11 at 10:57 AM
finance.yahoo.com logoNicox: Business Update and 2016 Financial Results
finance.yahoo.com - April 7 at 11:30 AM
finance.yahoo.com logoNICOX : Number of voting rights as of March 31, 2017
finance.yahoo.com - April 7 at 11:30 AM
finance.yahoo.com logoNICOX : Number of voting rights as of April 5, 2017
finance.yahoo.com - April 7 at 11:30 AM
americanbankingnews.com logo NICOX SA EUR1 (NICXF) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - April 4 at 12:43 AM
seekingalpha.com logoNICOX SA EUR ORD NEW (NICXF) Presents At Oppenheimer 27th Annual Healthcare Conference - Slideshow
seekingalpha.com - March 24 at 8:51 AM
seekingalpha.com logoNICOX SA EUR ORD NEW reports 1H results
seekingalpha.com - September 22 at 11:10 AM
finance.yahoo.com logoWhy Nicox (NICXF) Could Be a Potential Winner
finance.yahoo.com - August 1 at 8:38 AM
wsj.com logo[$$] Valeant: Not All Delays Are Created Equal
www.wsj.com - July 23 at 12:18 AM

Social

Chart

NICOX SA EUR1 (NICXF) Chart for Thursday, July, 20, 2017

This page was last updated on 7/20/2017 by MarketBeat.com Staff